Top 5 Most Influential Psychedelic Studies
We unpack five of the most important psychedelic studies conducted in recent years as psychedelics become mainstream medicine.
Author: James Hallifax
-
-
My Favorite Psychedelic Stocks: Part 1
Our resident Psychedelic Investor details five companies he thinks are in strong position to win the psychedelic medicine race.
-
Oklahoma House Passes Psilocybin Decriminalization Bill
Now it’s up to the state’s Senate to consider the bill decriminalizing the possession of psilocybin and authorizing research.
-
Study Finds Psilocybin Anti-Depression Effects Last at Least One Year
A year after a Johns Hopkins psilocybin-assisted therapy study, researchers find the number of people who benefited from receiving two doses actually increased.
-
How Long Until Psychedelic Stocks Payoff?
Our resident Psychedelic Investor explores one of the biggest questions on minds of those investing in psychedelic stocks.
-
Cathie Woods’ ARK Invest Conducting ‘Deep Dive’ Into Psychedelic Stocks
Cathie Wood and Ark Invest buying psychedelic stocks will be significant for the industry, as Wood holds a megaphone with which she communicates to retail growth investors.
-
Cathie Wood’s ARK Genomic Revolution ETF Buys Psychedelic Stock
Our resident Psychedelic Investor explains why this is an important moment for the psychedelics sector.
-
DMT Vape Pen Patent Illustrates a Big Problem in the Psychedelics Industry
Problematic patents have serious implications for the entire psychedelics industry.
-
The Thesis for Investing in Psychedelic Stocks
Our resident Psychedelic Investor makes the case why the psychedelic sector may yield big returns.
-
4 Tips for Investing in Psychedelic Stocks During a Market Downturn
Friendly advice for responsibly managing speculative bets on psychedelic stocks that may rise like a phoenix or burn to the ground.
